Answers are grounded in this paper and cite their sources.
The Smith—Lemli—Opitz Syndrome (SLOS) is a metabolic malformation and mentalretardation syndrome that is casued by a defect in cholesterol biosynthesis. The resultingloss of cholesterol leads to a spectrum from mild to very severe phenotype. The DHCR7 geneencodes Ä7 sterol reductase, the enzyme catalyzing the reduction of 7-dehydrocholesterolto cholesterol. This review provides an overview of knowledge about mutations leading toSLOS. It describes why and how age and origin of mutations are estimated. It demonstratesthat mutational spectra are population specific and that so-called null mutations have ahigh carrier frequency, probably not due to selection alone. Finally, a correlation betweenDHCR7 genotype and SLOS phenotype and a genetic modifying factor for this diseaseis described.
No takes yet. Share an insight, caveat, or question.
Martina Witsch‐Baumgartner (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: